These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Interleukins as drugs and objects of pharmacological action]. Uteshev BS Antibiot Khimioter; 1989 Nov; 34(11):869-74. PubMed ID: 2699219 [No Abstract] [Full Text] [Related]
6. TNF as immunomodulatory agent. Bonavida B Immunol Ser; 1992; 56():315-29. PubMed ID: 1550866 [No Abstract] [Full Text] [Related]
7. Mast cells to the defense. Galli SJ; Nakae S Nat Immunol; 2003 Dec; 4(12):1160-2. PubMed ID: 14639463 [No Abstract] [Full Text] [Related]
8. [Cytokines and severe infections]. Offenstadt G; Guidet B; Staikowsky F Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):820-31. PubMed ID: 8309725 [TBL] [Abstract][Full Text] [Related]
9. [Cytotoxic cytokines in multiple sclerosis]. Głabiński A Neurol Neurochir Pol; 1993; 27(6):869-75. PubMed ID: 8164782 [TBL] [Abstract][Full Text] [Related]
10. The role of TNFalpha and lymphotoxin in demyelinating disease. Lock C; Oksenberg J; Steinman L Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I121-8. PubMed ID: 10577988 [No Abstract] [Full Text] [Related]
11. Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Willenborg DO; Fordham SA; O'Brien NC; Cowden WB; Ramshaw IA Res Immunol; 1998; 149(9):804-10; discussion 849-50, 855-60. PubMed ID: 9923636 [No Abstract] [Full Text] [Related]
12. The tumor necrosis factors: cachectin and lymphotoxin. Beutler B Hosp Pract (Off Ed); 1990 Feb; 25(2):45-56. PubMed ID: 2105975 [TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response. Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010 [No Abstract] [Full Text] [Related]
14. TNF and viruses: multiple interrelationships. Rubin BY Immunol Ser; 1992; 56():331-40. PubMed ID: 1550867 [No Abstract] [Full Text] [Related]
15. Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody. Teramoto K; Baquerizo A; Imagawa DK; Seu P; Hart J; Dempsey RA; Terasaki PI; Kamada N; Busuttil RW Transplant Proc; 1991 Feb; 23(1 Pt 1):602-3. PubMed ID: 1990621 [No Abstract] [Full Text] [Related]
16. TNF production and hypertrophic scarring. Castagnoli C; Stella M; Berthod C; Magliacani G; Richiardi PM Cell Immunol; 1993 Mar; 147(1):51-63. PubMed ID: 8462114 [TBL] [Abstract][Full Text] [Related]
18. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin. Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413 [TBL] [Abstract][Full Text] [Related]
19. [The role of cytokines in ocular inflammation]. Rusiecka-Ziółkowska J; Misiuk-Hojło M Przegl Lek; 1997; 54(12):863-6. PubMed ID: 9591456 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Bendtzen K Immunol Lett; 1988 Nov; 19(3):183-91. PubMed ID: 3069706 [No Abstract] [Full Text] [Related] [Next] [New Search]